Often people believe inventors sit around waiting for good ideas to come to them, but the best ideas come naturally to those for whom innovation runs deep. This sentiment is certainly true for cardiologist Dan Cantillon, MD, whose innovative spirit was passed to him from his grandfather. In pursuing his dream to become a doctor, Dr. Cantillon wears this inventive trait on his sleeve. Day to day, he achieves his goal of helping the sickest patients get better, all the while continuing to innovate and create value in healthcare through spirit of change technologies. His most recent venture is that of the Advanced Cardiac Waveform Analytics (ACWA) platform to improve attention to detail in the care for cardiac patients.
Born out of a frontline caregiver’s observation of the need for consolidation of information collected from monitored cardiac patients, the ACWA technology aims to simplify and stratify electrocardiogram (ECG) data. The platform’s novelty lies in its ability to identify ‘hidden’ ECG signals that predict lethal arrhythmias, heart failure decompensation, and critical metabolic derangements. ACWA provides early detection and prediction of patient decline prior to clinical events like sudden cardiac arrest (SCA), atrial fibrillation (AFib), acute myocardial infarction (MI), and heart failure (HF). The automatic ECG interpretation is continuously fed into novel, interactive dashboard displays to enhance recognition and communication of essential findings across mobile and desktop healthcare software applications. These hidden signals trigger ‘smart precision alarms,’ bringing data to the physician, evoking a more significant investment in care.
Under Dr. Cantillon’s tutelage, Cleveland Clinic Innovations began working with an industry partner to co-develop the commercial version of the ACWA platform. Specializing in providing complete, enterprise-wide, vendor and data source-agnostic, mobile interoperability platforms for advanced care collaboration, this commercial partner holds the ability to integrate ACWA into clinical practice at Cleveland Clinic and beyond. The team overseeing the collaboration has protected the intellectual property and is moving at a rapid pace to develop and validate the technology in a world-class clinical setting. With industry partner expertise and continuous refinement of the technology, ACWA holds the potential to change the standard of care for cardiac patients around the globe.